One of the missions of NewG Lab Pharma (NGLP) is to develop novel anticancer therapeutics that extend the life of cancer patients without compromising their quality of life.
NewG Lab Pharma (NGLP) will try to achieve its mission by recognizing the importance of whole-body metabolism of cancer patients rather than focusing only on the reduction of tumor burden. Based on the published statistics there seems to be little correlation between overall survival benefits and tumor size.
Cancer, above all other diseases, has countless secondary causes. But, even for cancer, there is only one prime cause. Summarized in a few words, the prime cause of cancer is the replacement of the respiration of oxygen in normal body cells by a fermentation of sugar. Cancer should be interpreted as a mitochondrial dysfunction - Otto H. Warburg
Seminars with Georgia Medical Professionals
Seminars about Anti- Bacteria Treatment using 3BP with the University of Wroclaw, Poland.
Medical Week 2019 Baden-Baden, Germany Date: 30 October – 03 November 2019 Venue: Kongresshaus Betriebsgesellschaft mbH, Baden-Baden, Germany Website: http://www.medwoche.de/index.htm – Lecture: Krebskongress – Komplementäronkologie / Cancer Congress – Complementary Oncology – New information about our anticancer technology(03:00 pm – 03:30 pm) – Dr.
2019-05-17 NewG Lab Pharma, Inc. and KoDiscovery, LLC signed the contract : EXCLUSIVE PATENTS LICENSE CONTRACT AND TECHNOLOGY DEVELOPMENT AGREEMENT